Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation

NCT01265953 is registered in ClinicalTrials.gov with Portland VA Medical Center as lead sponsor.

NCT NCT01265953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01265953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation
Lead sponsor
Portland VA Medical Center
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2011
Completion date
December 31, 2015
Enrollment
98 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer prevention